Meta-DiSc A Software For Meta-Analysis of Test Accuracy Data
Meta-DiSc A Software For Meta-Analysis of Test Accuracy Data
Meta-DiSc A Software For Meta-Analysis of Test Accuracy Data
Methodology
BioMed Central
Open Access
Software
doi:10.1186/1471-2288-6-31
Abstract
Background: Systematic reviews and meta-analyses of test accuracy studies are increasingly being
recognised as central in guiding clinical practice. However, there is currently no dedicated and
comprehensive software for meta-analysis of diagnostic data. In this article, we present Meta-DiSc,
a Windows-based, user-friendly, freely available (for academic use) software that we have
developed, piloted, and validated to perform diagnostic meta-analysis.
Results: Meta-DiSc a) allows exploration of heterogeneity, with a variety of statistics including chisquare, I-squared and Spearman correlation tests, b) implements meta-regression techniques to
explore the relationships between study characteristics and accuracy estimates, c) performs
statistical pooling of sensitivities, specificities, likelihood ratios and diagnostic odds ratios using fixed
and random effects models, both overall and in subgroups and d) produces high quality figures,
including forest plots and summary receiver operating characteristic curves that can be exported
for use in manuscripts for publication. All computational algorithms have been validated through
comparison with different statistical tools and published meta-analyses. Meta-DiSc has a Graphical
User Interface with roll-down menus, dialog boxes, and online help facilities.
Conclusion: Meta-DiSc is a comprehensive and dedicated test accuracy meta-analysis software. It
has already been used and cited in several meta-analyses published in high-ranking journals. The
software is publicly available at http://www.hrc.es/investigacion/metadisc_en.htm.
Background
Accurate diagnosis forms the basis of good clinical care, as
without it one can neither prognosticate correctly nor
choose the right treatment. Indeed, a wrong diagnosis can
harm patients by exposing them to inappropriate or suboptimal therapy [1]. Thus studies of diagnostic accuracy,
and particularly their systematic reviews and meta-analyses, are being recognised as instrumental in underpinning
evidence-based clinical practice. Initiatives such as STARD
receiver operating characteristics (sROC) analysis. However, it is a DOS-based application with an interface that
many find difficult to use, and integrate into Windowsbased applications. Moreover, it lacks crucial analytical
tools such as pooling of likelihood ratios (LRs), tests for
heterogeneity and meta-regression facilities.
We, therefore, developed, piloted and validated a comprehensive, Windows-based test accuracy meta-analysis software, Meta-DiSc, which is presented in this article, with a
worked example.
Implementation
Meta-DiSc software was created in Microsoft Visual Basic
6, and some mathematical routines have been linked
from the NAG C mathematical library [5]. The software is
distributed as a single file, downloadable freely from URL:
Its
http://www.hrc.es/investigacion/metadisc_en.htm.
installation is simple, guided by onscreen instructions.
The programme has a user-friendly interface with rolldown menus, dialog boxes and online HTML compiled
help files. These help files include a user manual and a
description of the implemented statistical methods.
Meta-DiSc allows data entry into its datasheet in three different ways: a) directly by typing data into the datasheet
using the keyboard, b) copying from another spreadsheet
(e.g. Microsoft Excel) and pasting into Meta-DiSc datasheet, or c) importing text files from other sources (for example, in the comma delimited format). Several variables
can be defined in the datasheet, including study identifiers, accuracy data from each study (true positives, false
positives, true negatives and false negatives) and study
level co-variates, such as those defining population spectrum or methodological quality of the studies.
Once the data have been entered into the datasheet of
Meta-DiSc, various statistical analyses can be implemented (Figure 1). The implementation of these statistical
procedures needs to be carefully thought through and
judicious, as it may be inappropriate (or indeed misleading) to use all the procedures (particularly statistical pooling) in all reviews. Meta-DiSc provides analysts with
adequate tools to assess the appropriateness of pooling.
Readers interested in details of these methods are referred
to statistical methods section of the help files (also available as a PDF standalone document [6] and to existing
texts and guidelines on diagnostic meta-analysis [7-10].
Describing the results of individual studies
When describing accuracy results from several studies, it is
important to get an indication of the magnitude and precision of the accuracy estimates derived from each study,
as well as to assess the presence or absence of inconsistencies in accuracy estimates across studies (heterogeneity).
http://www.biomedcentral.com/1471-2288/6/31
Page 2 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
Page 3 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
Wherever possible, the results of the above statistical procedures were validated using different general purpose statistical software such as STATA (ver 8.2) and SAS (8.2)
using actually published and simulated data sets (Table
1).
Results
We illustrate the various procedures that Meta-DiSc
implements in a case-study of ultrasound test in the diagnosis of uterine pathology [21,22]. Ultrasound measurement of the lining of the uterus (endometrium) can
predict pathology such as endometrial hyperplasia (a precancerous condition) or cancer. The greater the thickness
of endometrium, the more likely that the target condition
is present. Various thresholds (such as 3, 4 or 5 mm etc)
have been used to define a positive ultrasound result.
A systematic review of test accuracy studies identified 57
studies. Figure 2 shows a datasheet in Meta-DiSc which
has been loaded with information from these 57 studies.
The information includes study identifiers, accuracy data,
Table 1: Validation of statistical procedures. Validation of different statistical procedures using a simulated data-set. Results of MetaDiSc (version 1.4) are compared with those obtained with metan (version 1.86) and metareg (version 1.06) STATA commands. Prior
to the analyses, all four cells of all studies were added with 1/2 to avoid division by zero when computing some indices or standard
errors. Meta-DiSc and STATA data-set are provided as additional files [see Additional file 1] and [see Additional file 2].
Results
Procedure
Pooled +ve LR
(95%(CI)
Tau-square
Cochrane-Q
2.447
(2.085 2.871)
0.0932
139.71
2.447
(2.085 2.871)
0.0932
139.71
Pooled -ve LR
(95%(CI)
Tau-square
Cochrane-Q
0.157
(0.095 0.257)
0.4631
33.00
0.157
(0.095 0.257)
0.46357
33.07
Pooled +ve LR
(95%(CI)
Cochrane-Q
2.330
(2.208 2.459)
139.71
2.330
(2.208 2.459)
139.71
Pooled -ve LR
(95%(CI)
Cochrane-Q
0.105
(0.073 0.149)
33.00
0.104
(0.073 0.148)
33.07
Tau-Square
Constant coefficient (SE)
S coefficient (SE)
Covariable coefficient (SE)
0.1141
2.520 (0.8370)
0.330 (0.1912)
-0.036 (0.0904)
0.1141
2.5197 (0.83699)
0.3304 (0.19123)
-0.0355 (0.09041)
Meta-Regression1
(1) Meta-regression was weighted by the inverse of the variance of dOR and between study variance was estimated by REML.
Page 4 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
Figure 2 datasheet
Meta-Disc
Meta-Disc datasheet. Meta-DiSc data set with details of test accuracy studies of ultrasound in the prediction of endometrial
cancer.
thresholds, and some study level co-variates (such as hormone replacement therapy use).
As the first step in the analysis, we have used Meta-DiSc to
present accuracy measures from each individual study in
forest plots for sensitivities (figure 3a), specificities (figure
3b), LRs (figures 4a and 4b) and dOR (figure 5). All these
indices can also be represented in tabular form as shown
in table 2. Although the forest plots and the tables contain
a pooled summary at the bottom, at this early stage in the
analysis, it is recommended that the plots are used to
obtain a general overview of the accuracy estimates from
each study, and the interpretation of the pooled summary
is left to later stages of analysis.
The next step is the representation of sensitivity against 1specificity from each study in a ROC space (figure 6),
which can be used for exploration for threshold effect. The
Page 5 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
A
Sensitivity (95% CI)
Auslender
Zannoni
Bakour
Botsis
Fistonic
Garuti
Granberg
Guner
Haller
Tsuda
Varner
Abu Ghazzeh
Briley
Cacciatore
DeSilva
Granberg
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Merz
Nasri
Nasri
Pertl
Suchocki
Taviani
Weber
Wolman
Moreles
Rudigoz
Todorova
Gruboeck
Chan
Degenhardt
Dijkhuizen
Brolmann
Ceccini
Masearetti
Mortakis
Schramm
Smith
Osmers
Seelbach-Gbel
Altuncu et al.
0,2
0,4
0,6
Sensitivity
0,8
1,00
0,98
1,00
1,00
1,00
0,98
1,00
1,00
1,00
0,93
1,00
1,00
1,00
1,00
0,33
1,00
1,00
1,00
0,67
0,86
1,00
0,93
1,00
1,00
1,00
1,00
1,00
0,95
1,00
1,00
0,98
1,00
0,91
0,78
1,00
0,82
1,00
0,86
1,00
1,00
0,94
1,00
1,00
0,62
1,00
1,00
0,95
0,83
(0,79 - 1,00)
(0,90 - 1,00)
(0,72 - 1,00)
(0,63 - 1,00)
(0,77 - 1,00)
(0,91 - 1,00)
(0,97 - 1,00)
(0,82 - 1,00)
(0,79 - 1,00)
(0,68 - 1,00)
(0,16 - 1,00)
(0,03 - 1,00)
(0,48 - 1,00)
(0,40 - 1,00)
(0,01 - 0,91)
(0,63 - 1,00)
(0,86 - 1,00)
(0,59 - 1,00)
(0,09 - 0,99)
(0,64 - 0,97)
(0,69 - 1,00)
(0,68 - 1,00)
(0,86 - 1,00)
(0,95 - 1,00)
(0,77 - 1,00)
(0,59 - 1,00)
(0,54 - 1,00)
(0,74 - 1,00)
(0,88 - 1,00)
(0,16 - 1,00)
(0,91 - 1,00)
(0,40 - 1,00)
(0,71 - 0,99)
(0,40 - 0,97)
(0,16 - 1,00)
(0,48 - 0,98)
(0,80 - 1,00)
(0,71 - 0,95)
(0,63 - 1,00)
(0,69 - 1,00)
(0,70 - 1,00)
(0,29 - 1,00)
(0,59 - 1,00)
(0,42 - 0,79)
(0,40 - 1,00)
(0,87 - 1,00)
(0,83 - 0,99)
(0,36 - 1,00)
Auslender
Zannoni
Bakour
Botsis
Fistonic
Garuti
Granberg
Guner
Haller
Tsuda
Varner
Abu Ghazzeh
Briley
Cacciatore
DeSilva
Granberg
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Merz
Nasri
Nasri
Pertl
Suchocki
Taviani
Weber
Wolman
Moreles
Rudigoz
Todorova
Gruboeck
Chan
Degenhardt
Dijkhuizen
Brolmann
Ceccini
Masearetti
Mortakis
Schramm
Smith
Osmers
Seelbach-Gbel
Altuncu et al.
0,2
0,4
0,6
Specificity
0,8
0,51
0,53
0,49
0,88
0,19
0,33
0,52
0,47
0,26
0,63
0,54
0,38
0,51
0,27
0,74
0,76
0,67
0,27
0,64
0,79
0,58
0,65
0,84
0,49
0,43
0,66
0,61
0,27
0,12
0,54
0,39
0,64
0,61
0,74
0,50
0,88
0,62
0,66
0,49
0,53
0,71
0,58
0,58
0,50
0,54
0,50
0,44
0,97
(0,42 - 0,61)
(0,49 - 0,57)
(0,38 - 0,60)
(0,80 - 0,93)
(0,12 - 0,29)
(0,28 - 0,38)
(0,49 - 0,55)
(0,39 - 0,55)
(0,16 - 0,39)
(0,55 - 0,71)
(0,25 - 0,81)
(0,28 - 0,49)
(0,43 - 0,58)
(0,14 - 0,43)
(0,60 - 0,86)
(0,70 - 0,82)
(0,60 - 0,73)
(0,11 - 0,50)
(0,52 - 0,75)
(0,67 - 0,87)
(0,46 - 0,69)
(0,54 - 0,75)
(0,74 - 0,91)
(0,38 - 0,60)
(0,28 - 0,59)
(0,52 - 0,78)
(0,50 - 0,72)
(0,19 - 0,35)
(0,06 - 0,20)
(0,37 - 0,70)
(0,29 - 0,50)
(0,49 - 0,77)
(0,53 - 0,68)
(0,59 - 0,86)
(0,16 - 0,84)
(0,80 - 0,94)
(0,47 - 0,75)
(0,55 - 0,75)
(0,36 - 0,62)
(0,39 - 0,66)
(0,66 - 0,76)
(0,33 - 0,80)
(0,45 - 0,69)
(0,42 - 0,58)
(0,37 - 0,69)
(0,43 - 0,57)
(0,36 - 0,51)
(0,85 - 1,00)
Figureplot
Forest
3
Forest plot. Forrest plot of sensitivities (3a) and specificities (3b) from test accuracy studies of ultrasound in the prediction of
endometrial cancer.
Page 6 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
A
Positive LR (95% CI)
Auslender
Zannoni
Bakour
Botsis
Fistonic
Garuti
Granberg
Guner
Haller
Tsuda
Varner
Abu Ghazzeh
Briley
Cacciatore
DeSilva
Granberg
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Merz
Nasri
Nasri
Pertl
Suchocki
Taviani
Weber
Wolman
Moreles
Rudigoz
Todorova
Gruboeck
Chan
Degenhardt
Dijkhuizen
Brolmann
Ceccini
Masearetti
Mortakis
Schramm
Smith
Osmers
Seelbach-Gbel
Altuncu et al.
0,01
1
Positive LR
1,99
2,09
1,89
7,36
1,20
1,47
2,07
1,83
1,32
2,52
1,79
1,21
1,85
1,24
1,31
3,94
2,95
1,31
1,85
4,00
2,27
2,65
5,96
1,96
1,70
2,74
2,40
1,29
1,12
1,80
1,62
2,48
2,31
2,98
1,67
7,04
2,54
2,52
1,86
2,02
3,27
2,06
2,21
1,24
1,94
1,96
1,68
29,17
(1,62 - 2,45)
(1,92 - 2,28)
(1,49 - 2,41)
(4,44 - 12,21)
(1,04 - 1,38)
(1,36 - 1,59)
(1,93 - 2,21)
(1,57 - 2,14)
(1,12 - 1,56)
(1,96 - 3,22)
(0,84 - 3,83)
(0,54 - 2,75)
(1,40 - 2,47)
(0,88 - 1,75)
(0,24 - 6,96)
(2,93 - 5,28)
(2,43 - 3,57)
(0,96 - 1,79)
(0,78 - 4,35)
(2,47 - 6,47)
(1,69 - 3,05)
(1,94 - 3,63)
(3,65 - 9,73)
(1,59 - 2,42)
(1,29 - 2,24)
(1,83 - 4,10)
(1,71 - 3,37)
(1,11 - 1,50)
(1,03 - 1,22)
(0,98 - 3,30)
(1,37 - 1,90)
(1,56 - 3,96)
(1,85 - 2,90)
(1,64 - 5,43)
(0,73 - 3,81)
(3,69 - 13,42)
(1,78 - 3,64)
(1,86 - 3,41)
(1,39 - 2,49)
(1,49 - 2,74)
(2,65 - 4,02)
(1,10 - 3,87)
(1,60 - 3,06)
(0,90 - 1,71)
(1,25 - 3,00)
(1,70 - 2,27)
(1,45 - 1,94)
(4,09 - 208,02)
Auslender
Zannoni
Bakour
Botsis
Fistonic
Garuti
Granberg
Guner
Haller
Tsuda
Varner
Abu Ghazzeh
Briley
Cacciatore
DeSilva
Granberg
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Merz
Nasri
Nasri
Pertl
Suchocki
Taviani
Weber
Wolman
Moreles
Rudigoz
Todorova
Gruboeck
Chan
Degenhardt
Dijkhuizen
Brolmann
Ceccini
Masearetti
Mortakis
Schramm
Smith
Osmers
Seelbach-Gbel
Altuncu et al.
0,01
1
Negative LR
0,06
0,03
0,08
0,06
0,17
0,05
0,01
0,05
0,11
0,11
0,31
0,65
0,16
0,37
0,90
0,07
0,03
0,22
0,52
0,18
0,08
0,10
0,02
0,01
0,08
0,10
0,12
0,20
0,14
0,31
0,04
0,16
0,15
0,30
0,33
0,21
0,04
0,21
0,11
0,09
0,09
0,22
0,11
0,76
0,19
0,04
0,12
0,17
(0,00 - 0,88)
(0,00 - 0,24)
(0,01 - 1,28)
(0,00 - 0,94)
(0,01 - 2,70)
(0,01 - 0,35)
(0,00 - 0,13)
(0,00 - 0,83)
(0,01 - 1,75)
(0,02 - 0,71)
(0,02 - 4,09)
(0,06 - 7,30)
(0,01 - 2,35)
(0,03 - 5,30)
(0,40 - 2,03)
(0,00 - 1,08)
(0,00 - 0,47)
(0,01 - 3,50)
(0,10 - 2,61)
(0,06 - 0,52)
(0,01 - 1,18)
(0,02 - 0,69)
(0,00 - 0,36)
(0,00 - 0,23)
(0,00 - 1,21)
(0,01 - 1,40)
(0,01 - 1,69)
(0,03 - 1,36)
(0,01 - 2,31)
(0,02 - 3,96)
(0,01 - 0,29)
(0,01 - 2,19)
(0,04 - 0,56)
(0,09 - 1,03)
(0,02 - 4,55)
(0,06 - 0,72)
(0,00 - 0,70)
(0,09 - 0,47)
(0,01 - 1,69)
(0,01 - 1,31)
(0,01 - 0,59)
(0,02 - 2,99)
(0,01 - 1,60)
(0,46 - 1,24)
(0,01 - 2,63)
(0,00 - 0,56)
(0,03 - 0,46)
(0,03 - 1,03)
Figureplot
Forest
4
Forest plot. Forrest plot of likelihood ratios for positive (4a) and negative (4b) test results from studies of ultrasound in the
prediction of endometrial cancer.
Page 7 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
0,01
1
Diagnostic Odds Ratio
Figure 5
Forrest
plot
Forrest plot. Forest plot of diagnostic odds ratios (dOR) from test accuracy studies of ultrasound in the prediction of
endometrial cancer.
Page 8 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
Table 2: Tabulation of Likelihood ratio for positive test result (LR+) with respective 95% confidence intervals from all test accuracy
studies included in systematic review of ultrasound for prediction of endometrial cancer.
Study
LR+
Auslender
Zannoni
Bakour
Botsis
Fistonic
Garuti
Granberg
Guner
Haller
Tsuda
Varner
Abu Ghazzeh
Briley
Cacciatore
DeSilva
Granberg
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Merz
Nasri
Nasri
Pertl
Suchocki
Taviani
Weber
Wolman
Moreles
Rudigoz
Todorova
Gruboeck
Chan
Degenhardt
Dijkhuizen
Brolmann
Ceccini
Masearetti
Mortakis
Schramm
Smith
Osmers
Seelbach-Gbel
Altuncu et al.
1,994
2,092
1,895
7,360
1,200
1,471
2,066
1,834
1,321
2,517
1,795
1,215
1,855
1,239
1,306
3,937
2,946
1,307
1,846
4,000
2,273
2,649
5,957
1,963
1,697
2,740
2,400
1,293
1,120
1,802
1,618
2,481
2,312
2,981
1,667
7,036
2,543
2,516
1,859
2,017
3,267
2,059
2,213
1,241
1,938
1,964
1,680
29,167
1,623
1,919
1,490
4,437
1,045
1,358
1,935
1,569
1,118
1,964
0,842
0,538
1,396
0,877
0,245
2,933
2,430
0,956
0,783
2,472
1,691
1,936
3,648
1,591
1,287
1,833
1,711
1,115
1,027
0,983
1,374
1,556
1,845
1,638
0,729
3,689
1,779
1,856
1,389
1,487
2,655
1,096
1,602
0,899
1,252
1,699
1,455
4,089
-2,449
-2,280
-2,408
-12,208
-1,378
-1,593
-2,206
-2,144
-1,561
-3,225
-3,826
-2,745
-2,465
-1,752
-6,957
-5,284
-3,572
-1,787
-4,350
-6,473
-3,054
-3,627
-9,729
-2,421
-2,236
-4,096
-3,367
-1,499
-1,222
-3,304
-1,904
-3,956
-2,896
-5,426
-3,808
-13,422
-3,635
-3,411
-2,489
-2,736
-4,021
-3,866
-3,058
-1,714
-3,001
-2,271
-1,940
-208,02
2,087
1,881
-2,315
% Weight
2,54
2,77
2,45
1,69
2,69
2,78
2,79
2,65
2,63
2,43
1,13
1,03
2,33
2,15
0,34
2,30
2,57
2,25
0,96
1,76
2,30
2,24
1,73
2,53
2,35
1,98
2,17
2,67
2,77
1,44
2,64
1,80
2,49
1,46
1,01
1,35
2,12
2,27
2,31
2,27
2,54
1,38
2,22
2,22
1,88
2,68
2,68
0,25
Page 9 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
Table 3: Results of Spearman rank correlation of sensitivity against (1 specificity) to assess the threshold effect in all test accuracy
studies included in systematic review of ultrasound for prediction of endometrial cancer.
Var.
Coeff.
Std. Error
p-value
A
b(1)
2.412
0.187
0.292
0.101
8.266
1.857
0.0000
0.0697
Table 4: Results of meta-regression analysis for predicting the presence or absence of endometrial carcinoma with variables: use or
non-use of hormone replacement therapy (HRT); technique of ultrasound measurement (single or double layer); and population
enrolment (consecutive or other).
p-value
RDOR
[95%CI]
Cte.
S
Layers
Consecutive
HRT
0,1571
0,0208
0,0610
0,7398
0,4152
------2,03
1,23
1,38
------(0,97;4,27)
(0,35;4,26)
(0,63;3,06)
p-value
RDOR
[95%CI]
Cte.
S
Layers
HRT
0,1565
0,0194
0,0424
0,4152
------2,09
1,38
------(1,03;4,27)
(0,63;3,02)
p-value
RDOR
[95%CI]
Cte.
S
Layers
0,0999
0,0166
0,0482
------2,04
------(1,01;4,13)
0,857
0,263
0,709
0,206
0,324
0,849
0,253
0,739
0,320
0,959
0,258
0,712
Page 10 of 12
(page number not for citation purposes)
Sensitivity
1
http://www.biomedcentral.com/1471-2288/6/31
ROC space
0,9
Abu Ghazzeh
Briley
Cacciatore
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Nasri
Suchocki
Taviani
Weber
Wolman
0,8
0,7
0,6
0,5
1,21
1,85
1,24
2,95
1,31
1,85
4,00
2,27
2,65
5,96
1,96
2,74
1,12
1,80
1,62
2,48
(0,54 - 2,75)
(1,40 - 2,47)
(0,88 - 1,75)
(2,43 - 3,57)
(0,96 - 1,79)
(0,78 - 4,35)
(2,47 - 6,47)
(1,69 - 3,05)
(1,94 - 3,63)
(3,65 - 9,73)
(1,59 - 2,42)
(1,83 - 4,10)
(1,03 - 1,22)
(0,98 - 3,30)
(1,37 - 1,90)
(1,56 - 3,96)
0,4
0,3
0,01
0,2
0,1
1
Positive LR
0,2
0,4
0,6
0,8
Abu Ghazzeh
Briley
Cacciatore
Grigoriou
Gu
Gupta
Hnggi
Ivanov
Karlsson
Loverro
Malinova
Nasri
Suchocki
Taviani
Weber
Wolman
1-specificity
Figure
ROC
Space
6
ROC Space. Representation of sensitivity against (1-specificity) in Receiver Operating Characteristics space for each
study of ultrasound in the prediction of endometrial cancer.
0,01
Sensitivity
1
1
Negative LR
0,65
0,16
0,37
0,03
0,22
0,52
0,18
0,08
0,10
0,02
0,01
0,10
0,14
0,31
0,04
0,16
(0,06 - 7,30)
(0,01 - 2,35)
(0,03 - 5,30)
(0,00 - 0,47)
(0,01 - 3,50)
(0,10 - 2,61)
(0,06 - 0,52)
(0,01 - 1,18)
(0,02 - 0,69)
(0,00 - 0,36)
(0,00 - 0,23)
(0,01 - 1,40)
(0,01 - 2,31)
(0,02 - 3,96)
(0,01 - 0,29)
(0,01 - 2,19)
Figure 7
Forrest
plot
Forrest plot. Forrest plots of Likelihood ratios for positive
(7a) and negative (7b) test results in one homogenous subgroup of studies of non-HRT users, with a test threshold of
5 mm, and using a single layer technique.
SROC Curve
Symmetric SROC
AUC = 0,8012
SE(AUC) = 0,0562
Q* = 0,7369
SE(Q*) = 0,0491
0,9
0,8
0,7
0,6
0,5
0,4
0,3
0,2
0,1
0,2
0,4
0,6
0,8
1-specificity
Figurecurve
sROC
8
sROC curve. Receiver operating characteristics curve for
all studies included in systematic review of ultrasound for
prediction of endometrial cancer.
Page 11 of 12
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2288/6/31
9.
10.
Competing interests
11.
12.
Authors' contributions
13.
JZ conceived the idea. AM, VA and JZ developed the software. AC and KSK tested the software on a number of
reviews and gave suggestions for improvements. All
authors participated in preparing this manuscript.
14.
15.
Additional material
Additional File 1
Meta-Disc data set. This file contains simulated data. It is provided to help
users to validate statistical procedures shown in table 1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712288-6-31-S1.dsc]
Additional File 2
STATA data set. This file contains simulated data. It is provided to help
users to validate statistical procedures shown in table 1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712288-6-31-S2.dta]
Acknowledgements
This work has been partly funded by Spanish Health Ministry Grants no
PI02/0954, G03/090 and PI04/1055.
16.
17.
18.
19.
20.
21.
22.
23.
24.
References
1.
2.
3.
4.
5.
6.
7.
8.
25.
26.
27.
28.
Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der
Windt DA, Bezemer PD: Conducting systematic reviews of
diagnostic studies: didactic guidelines. BMC Med Res Methodol
2002, 2:9.
Deeks JJ: Systematic reviews of evaluations of diagnostic and
screening tests studies. In Systematic reviews in health care: metaanalysis in context 2nd Edition edition. Edited by: Egger M, Davey SG
and Altman DG. BMJ Books; 2001.
Honest H, Khan KS: Reporting of measures of accuracy in systematic reviews of diagnostic literature. Bmc Health Services
Research 2002, 2:.
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56:1129-1135.
Lijmer JG, Bossuyt PM, Heisterkamp SH: Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med
2002, 21:1525-1537.
Dinnes J, Deeks J, Kirby J, Roderick P: A methodological review
of how heterogeneity has been examined in systematic
reviews of diagnostic test accuracy. Health Technol Assess 2005,
9:1-113.
Higgins JP, Thompson SG: Quantifying heterogeneity in a metaanalysis. Stat Med 2002, 21:1539-1558.
Thompson SG, Sharp SJ: Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999, 18:2693-2708.
Rutter CM, Gatsonis CA: A hierarchical regression approach to
meta-analysis of diagnostic test accuracy evaluations. Stat
Med 2001, 20:2865-2884.
Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH: Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.
Journal of Clinical Epidemiology 2005, 58:982-990.
Walter SD: Properties of the summary receiver operating
characteristic (SROC) curve for diagnostic test data. Stat
Med 2002, 21:1237-1256.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control
Clin Trials 1986, 7:177-188.
Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS: Ultrasonographic
endometrial thickness for diagnosing endometrial pathology
in women with postmenopausal bleeding: a meta-analysis.
Acta Obstet Gynecol Scand 2002, 81:799-816.
Khan KS, Kunz R, Kleijnen J, Antes G: Case study 4: Reviewing
evidence on test accuracy. In Systematic Review to Support Evidence-based Medicine 2003 edition. London, The Royal Society of
Medicine; 2003:109-119.
Morgan M, Kalantri S, Flores L, Pai M: A commercial line probe
assay for the rapid detection of rifampicin resistance in
Mycobacterium tuberculosis: a systematic review and metaanalysis. BMC Infectious Diseases 2005, 5:62.
Flores L, Pai M, Colford JM, Riley LW: In-house nucleic acid
amplification tests for the detection of Mycobacterium
tuberculosis in sputum specimens: meta-analysis and metaregression. BMC Microbiol 2005, 5:55.
Gisbert J, Abraira V: Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis.
The American Journal of
Gastroenterology 2006, 101:848-863.
Shiga T, Wajima Z, Inoue T, Sakamoto A: Predicting difficult intubation in apparently normal patients: a meta-analysis of bedside screening test performance.
Anesthesiology 2005,
103:429-437.
Zijlstra JM, van der Werf G, Hoekstra OS, Hooft L, Huijgens PC: Ffluoro-deoxyglucose positron emission tomography for posttreatment evaluation of malignant lymphoma: a systematic
review. Haematologica 2006, 91:522-9.
Goodacre S, Sutton AJ, Sampson FC: Meta-Analysis: The Value of
Clinical Assessment in the Diagnosis of Deep Venous
Thrombosis. Annals of Internal Medicine 2005, 143:129-139.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2288/6/31/prepub
Page 12 of 12
(page number not for citation purposes)